New pill aims to shield kids with sickle cell from devastating strokes

NCT ID NCT05953584

Recruiting now Disease control Sponsor: Forma Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new daily pill called etavopivat to see if it can lower the high risk of stroke in children with sickle cell disease. It will involve about 27 children aged 12-16 who have fast blood flow in their brain arteries, a key warning sign for stroke. The main goal is to see if taking the medicine for one year safely reduces this dangerous blood flow speed.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

All India Institute of Medical Sciences (AIIMS), Raipur
RECRUITING

Raipur, Chhattisgarh, 492099, India
All India Institute of Medical Sciences-Delhi
RECRUITING

Delhi, 110029, India
Aminu Kano Teaching Hospital (AKTH)
RECRUITING

Tarauni, 700101, Nigeria
Indira Gandhi Government Medical College & Hospital
NOT_YET_RECRUITING

Nagpur, 440018, India
Lagos University Teaching Hospital, Lagos
RECRUITING

Lagos, 102215, Nigeria
Nirmal Hospital Pvt. Ltd.
RECRUITING

Gujarat, 395002, India
Sultan Qaboos University Hospital
RECRUITING

Muscat, Sultanet of Oman/Muscat/Al Khoud, 123, Oman
Suretech Hospital and Research Centre Ltd.
RECRUITING

Maharashtra, 440012, India
University of Ibadan, University College Hospital
RECRUITING

Ibadan, 200285, Nigeria

Conditions

Explore the condition pages connected to this study.

SICKLE CELL DISEASE